Inicio>>Peptides>> Amyloid β protein>>Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide

Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide

Catalog No.GA20526

The pentapeptide Ac-LPFFD-NH? (iAβ5p) is an analog of product H-4876 with small chemical modifications which enhance its stability against proteolytic degradation. iAβ5p acts as a β-sheet breaker peptide and crosses the blood-brain barrier at a higher rate than most proteins and peptides known to be selectively taken up by the brain so that it is assumed that the peptide is being specifically transported to the brain. A significant increase in neuronal survival and decrease in brain inflammation associated with the reduction of amyloid plaques in two different transgenic Alzheimer`s disease (AD) models is additionally reported for iAβ5p.

Products are for research use only. Not for human use. We do not sell to patients.

Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide Chemical Structure

Cas No.: 339990-02-2

Tamaño Precio Disponibilidad Cantidad
5mg
97,00 $
Disponible
25mg
371,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The pentapeptide Ac-LPFFD-NH (iAβ5p) is an analog with small chemical modifications which enhance its stability against proteolytic degradation. iAβ5p acts as a β-sheet breaker peptide and crosses the blood-brain barrier at a higher rate

Reseñas

Review for Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.